Editas Medicine (EDIT)
(Real Time Quote from BATS)
$10.71 USD
+0.10 (0.94%)
Updated Nov 30, 2023 09:30 AM ET
3-Hold of 5 3
F Value C Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
02/28/2024
Time: -- |
12/2023 | $-0.61 | 2.37% |
Earnings Summary
For their last quarter, Editas Medicine (EDIT) reported earnings of -$0.55 per share, beating the Zacks Consensus Estimate of $-0.64 per share. This reflects a positive earnings surprise of 14.06%. Look out for EDIT's next earnings release expected on February 28, 2024. For the next earning release, we expect the company to report earnings of -$0.61 per share, reflecting a year-over-year increase of 30.68%.
Earnings History
Price & Consensus
Zacks News for EDIT
Editas (EDIT) Q3 Earnings & Revenues Beat, Pipeline in Focus
EDIT: What are Zacks experts saying now?
Zacks Private Portfolio Services